BioAffinity Technologies

BioAffinity Technologies is a biotechnology company focused on developing non-invasive diagnostics and targeted therapeutics for early-stage cancer detection and treatment. Operating in the healthcare and medical research market, the company serves patients, healthcare providers, and research institutions. BioAffinity Technologies utilizes advanced scientific research and innovative techniques, such as porphyrin molecules that bind to cancer cells and fluoresce to distinguish them from non-cancerous cells. The business model revolves around the development and commercialization of these diagnostic tools and treatments, generating revenue through product sales, partnerships, and licensing agreements. The company collaborates with institutions like the University of Texas Health Science Center to advance its research and product offerings.

Keywords: biotechnology, cancer diagnostics, targeted therapeutics, non-invasive, early detection, porphyrin molecules, healthcare, medical research, commercialization, collaboration.